Aiming at the investigation on whether the HFD & D-gal model could cause hyperphosphorylation of tau protein in the hippocampus of mice, a typical pathological manifestation of AD [21], and the therapeutic impact of BYHWD on this pathological manifestation, immunohistochemical staining was accomplished. This evidence concerns the gene MAPT and Alzheimer disease.